Fundraising FoxHealthtech Startups
18,759 companies tagged Healthtech, with their investors and founders.
0 investors
0 investors
0 investors
0 investors
MINDSET Integrated provides science-based brain analysis tools and software for medical-legal applications, delivering quantitative imaging analysis and case management solutions for legal and healthcare professionals involved in complex brain injury litigation and diagnostics.
0 investors
MindWave Medical develops medical technology solutions for critical care settings. The company's offerings serve hospital teams managing critically ill patients.
0 investors
Minerva Biotechnologies develops cancer and stem cell therapeutics, including cancer immunotherapies aimed at solid tumors and preventing cancer metastasis. The company also works on patient-derived stem cells for regenerative medicine.
0 investors
MingSight Pharmaceuticals is a clinical-stage biopharmaceutical company developing MS-553, an orally administered selective protein kinase C (PKC) inhibitor. Its lead candidate targets diabetic macular edema and diabetic retinopathy in ophthalmology, as well as chronic lymphocytic leukemia and small lymphocytic lymphoma in oncology.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
Mitesco operates a data center and cloud computing services business through its subsidiary Centcore, offering managed hosting and colocation services, while its subsidiary Vero Technology Ventures develops artificial intelligence-based applications for cloud platforms, including a sales automation tool called Robo Agent targeting residential real estate and other consumer-facing markets.
0 investors
Mitochon is an early-stage biopharmaceutical company developing therapeutics. The page does not provide details about specific products, target indications, or customer segments beyond the biopharmaceutical sector.
0 investors
0 investors
MitoSense develops Mitochondria Organelle Transplantation (MOT) technology, a cellular biotherapy that uses mitochondria to treat neurodegenerative diseases such as ALS, Parkinson's, and Alzheimer's. The company holds an exclusive license to the MOT technology and is developing it as a cell therapy.
0 investors
0 investors